| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |